MYC and neoplasm: Specifically, tumor-derived EVs carrying c-Myc blocked miR-556-3p expression by upregulating KCNQ1OT1 to elevate CLIC1 expression, thus activating the PI3K/AKT pathway and accelerating GC cell proliferation, invasion, and migration (Fig. 8).